Effect of antihypertensive medications on the risk of open-angle glaucoma

被引:7
作者
Lee, Jihei Sara [1 ]
Cha, Hye Ryeong [2 ]
Bae, Hyoung Won [1 ]
Lee, Sang Yeop [1 ,3 ]
Choi, Wungrak [1 ]
Lee, Seung Won [4 ]
Kim, Chan Yun [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Inst Vis Res, Dept Ophthalmol, 50 Yonsei Ro, Seoul 03722, South Korea
[2] Sungkyunkwan Univ, Dept Comp Sci & Engn, Suwon, South Korea
[3] Yonsei Univ, Yongin Severance Hosp, Coll Med, Dept Ophthalmol, Yongin, South Korea
[4] Sungkyunkwan Univ, Sch Med, Dept Precis Med, 2066 Seobu Ro, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE; INTRAOCULAR-PRESSURE; ARTERIAL STIFFNESS; ASSOCIATION; PROGRESSION; HYPERTENSION; REDUCTION; BLOCKER;
D O I
10.1038/s41598-023-43420-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of this study was to identify the effect of antihypertensive medication on risks of open-angle glaucoma (OAG) among patients diagnosed with hypertension (HTN). A total of 5,195 patients, who were diagnosed with HTN between January 1, 2006 and December 31, 2015, and subsequently diagnosed with OAG, were selected for analysis. For each OAG patient, 5 non-glaucomatous, hypertensive controls were matched (n = 25,975) in hypertension diagnosis date, residential area, insurance type and economic status. Antihypertensive medications were stratified into 5 types: angiotensin converting enzyme inhibitor (ACEi), angiotensin receptor blockers (ARB), calcium channel blockers (CCB), beta-blockers and diuretics. Relative risks were calculated. After adjusting for age, sex, body mass index, lifestyle, comorbidities, blood pressure (BP), follow-up duration, and use of other types of antihypertensive drugs, ARB and CCB were found to slightly increase OAG risks (RR 1.1087 (95% CI 1.0293-1.1942); 1.0694 (1.0077-1.1349), respectively). Combinations of ARB with diuretics (1.0893 (1.0349-1.1466)) and CCB (1.0548 (1.0122-1.0991)) also increased OAG risks. The risks for OAG were found to increase by antihypertensive medication use, but the effects appeared to be small. Further studies are necessary to identify the associations of increased BP, medication and therapeutic effect with OAG.
引用
收藏
页数:11
相关论文
共 54 条
[1]   SUSTAINED REDUCTION OF INTRAOCULAR-PRESSURE IN HUMANS WITH THE CALCIUM-CHANNEL BLOCKER VERAPAMIL [J].
ABELSON, MB ;
GILBERT, CM ;
SMITH, LM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 105 (02) :155-159
[2]   Calcium-antagonist drugs [J].
Abernethy, DR ;
Schwartz, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (19) :1447-1457
[3]   Treatment of Resistant and Refractory Hypertension [J].
Acelajado, Maria Czarina ;
Hughes, Zachary H. ;
Oparil, Suzanne ;
Calhoun, David A. .
CIRCULATION RESEARCH, 2019, 124 (07) :1061-1070
[4]   Use of calcium channel blockers for glaucoma [J].
Araie, Makoto ;
Mayama, Chihiro .
PROGRESS IN RETINAL AND EYE RESEARCH, 2011, 30 (01) :54-71
[5]   Autonomic Dysfunction and Blood Pressure in Glaucoma Patients: The Lifelines Cohort Study [J].
Asefa, Nigus G. ;
Neustaeter, Anna ;
Jansonius, Nomdo M. ;
Snieder, Harold .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (11)
[6]   Systemic Hypertension as a Risk Factor for Open-Angle Glaucoma: A Meta-Analysis of Population-Based Studies [J].
Bae, Hyoung Won ;
Lee, Naeun ;
Lee, Hye Sun ;
Hong, Samin ;
Seong, Gong Je ;
Kim, Chan Yun .
PLOS ONE, 2014, 9 (09)
[7]   Risk factors and open-angle glaucoma: Classification and application [J].
Boland, Michael V. ;
Quigley, Harry A. .
JOURNAL OF GLAUCOMA, 2007, 16 (04) :406-418
[8]   Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension [J].
Chen, J. M. H. ;
Heran, B. S. ;
Perez, M., I ;
Wright, J. M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01)
[9]   Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study [J].
Choi, Hyon K. ;
Soriano, Lucia Cea ;
Zhang, Yuqing ;
Garcia Rodriguez, Luis A. .
BRITISH MEDICAL JOURNAL, 2012, 344
[10]  
Chong Rachel S, 2021, Ophthalmology, V128, P393, DOI 10.1016/j.ophtha.2020.07.051